Republic of Korea

8 Vaccines Approved for Use in Republic of Korea

• Novavax
  Nuvaxovid

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 40 countries

  22 trials in 14 countries

  Approval Source: reuters.com

  Protein Subunit

• SK Bioscience Co Ltd
  SKYCovione

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 6 countries

  Approval Source: ipd.uw.edu

  Protein Subunit

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 88 countries

  70 trials in 24 countries

  Approval Source: modernatx.gcs-web.com

  RNA

• Moderna
  Spikevax Bivalent Original/Omicron BA.1

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 38 countries

  5 trials in 4 countries

  Approval Source: kukinews.com

  RNA

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  100 trials in 31 countries

  Approval Source: asia.nikkei.com

  RNA

• Pfizer/BioNTech
  Comirnaty Bivalent Original/Omicron BA.1

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 35 countries

  3 trials in 5 countries

  Approval Source: koreabiomed.com

  RNA

• Janssen (Johnson & Johnson)
  Jcovden

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 113 countries

  26 trials in 25 countries

  Approval Source: mfds.go.kr

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

9 Vaccines in Clinical Trials in Republic of Korea

• EuBiologics Co Ltd
  EuCorVac-19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  4 trials in 3 countries

  Protein Subunit

• SK Bioscience Co Ltd
  SKYCovione

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 6 countries

  Protein Subunit

• Inovio
  INO-4800

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  10 trials in 9 countries

  DNA

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Non Replicating Viral Vector

• GeneOne Life Science, Inc.
  GLS-5310

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  4 trials in 2 countries

  DNA

• Cellid Co
  AdCLD-CoV19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  5 trials in 1 country

  Replicating Viral Vector

• SK Bioscience Co Ltd
  NBP2001

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Protein Subunit

• HK inno.N Corporation
  IN-B009

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Protein Subunit

• Cellid Co
  AdCLD-CoV19-1

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Non Replicating Viral Vector

1 Vaccines with Trials in Republic of Korea are No Longer Progressing

• Genexine
  GX-19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  7 trials in 1 country

  DNA